Inari Expands Board of Directors with Appointment of Bob Bechek

CAMBRIDGE, MASS. — Jan. 5, 2021 — Inari, a biotech seed company, today announced that Bob Bechek has been appointed to its board of directors.

Bechek is a partner and former worldwide managing director (CEO) and board chair of consulting firm Bain & Company. His appointment, effective Jan. 1, 2021, brings the Inari board to seven members.

“Bob joins the Inari board at a very exciting time and his experience in the technology sector will be very helpful to us,” said Michael Mack, Inari executive chairman. “Furthermore, he is considered a subject matter expert on orchestrating transformational change, which will be a feature of the global seeds landscape over the coming years, driven by the exciting technologies which will be introduced. On behalf of the entire board, we welcome and look forward to working with Bob.”

Across his 32 years at Bain & Company, Bechek has held many other leadership and governance roles, including co-head of the firm’s Global Telecom, Media & Technology practice. He received his MBA from Harvard Business School and a Bachelor of Science degree in mechanical engineering from the Massachusetts Institute of Technology (MIT).

“I look forward to joining such a mission-driven company,” said Bechek. “In addition to the opportunity to build a strong business, Inari’s promising technology has significant scope to address important global issues of sustainability that are so urgently needed.”

About Inari
Founded by Flagship Pioneering in 2016, Inari is embracing diversity to build a new, more sustainable food system using unsurpassed technology to unlock the full potential of seed. Through its SEEDesign^TM platform, Inari unlocks new possibilities using predictive design and advanced multiplex gene editing to bring step-change products to market. Based in Cambridge, Massachusetts, with development sites in West Lafayette, Indiana, and Ghent, Belgium, Inari is a growing team of more than 160 employees. To learn more, visit Inari.com.